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THE INDUCTION of lung neoplasms by
hydrazine sulphate in mice was reported
by Biancifiori and Ribacchi in 1962.
Subsequently, a series of hydrazine deri-
vatives have been shown to be tumour
producing substances (Clayson et al.,
1966; Druckrey et al., 1967; Roe, Grant
and Millican, 1967; Kelly et al., 1969;
Osswald and Kruger, 1969; Wiebecke etal.,
1969; Innes et al., 1969; Schauer, Vollnagel
and Wildanger, 1969; Druckrey, 1970).
Very few of them have thus far given
negative results (Cremlyn and Roe, 1971).
Systematic tumorigenesis studies with
substituted hydrazines in this laboratory
have been performed in two species,
randomly bred Swiss albino mice and
Syrian golden hamsters. At first, toxicity
studies were carried out using each
chemical. Afterwards, the maximum
tolerated dose was given orally ad libitum
for life.
MATERIAL AND METHODS
Swiss albino mice from the colony ran-
domly bred by us since 1951 were used.
They were housed in plastic cages with
granular cellulose bedding, separated accord-
ing to sex in groups of 10, and given Wayne
lab-blox diet in regular pellets (Allied Mills,
Inc., Chicago, Illinois) and tap water or the
test solution ad libitum as described below.
The chemical used was n-amylhydrazine
hydrochloride (AH), CH3-CH2-CH2-CH2-
CH2-NH-NH2.HCL, Mol wt: 138-64, m.p.
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> 300°C, purity greater than 98% by gas
chromatography. Furthermore, the
0-00625% solution which had been used for
the chronic experiment was reanalysed by gas
chromatography after 48 h standing and
found still to contain greater than 98% ofthe
original compound unchanged.
Synthesi.s of n-amylhydrazine oxalate.-
With vigorous stirring, 30 g of n-amyl-
bromide is added dropwise to 100 g of
hydrazine hydrate at 45°C. After stirring for
4 h the resultant solution was continuously
extracted with ether for 20 h. The ether was
removed by distillation and the residue
poured into 35 g of oxalic acid in 400 ml of
95% ethanol. The resultant oxalate salt was
filtered and recrystallized from ethanol (m.p.
164-50C).
Preparations of n-amylhydrazine hydro-
chloride, and the stock solution.-The above
oxalate was added to a cold solution contain-
ing an equal weight of sodium hydroxide and
400 ml of water. The solution was distilled
to near dryness (370 ml ofdistillate collected).
An aliquot of the distillate was titrated with
0-1 N HCI to a methyl red end-point and the
concentration of n-amylhydrazine was calcu-
lated. The distillate was acidified with HCI
to a pH of 4-5 and the concentration of the
hydrazine adjusted to 5%. The solution was
stored in a dark bottle under refrigeration.
The level of the chemical to be admin-
istered in the chronic study was determined
to be 0.00625% by the technique of Toth
(1972a).
The solution was prepared thrice weekly
and the total consumption ofwater containing
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AH wAas measured at intervals during the
treatment period. The solution wN-as contained
in brown bottles because of the possible light
sensitivity of the chemical. The chronic
experimental groups and the controls were as
followNs:
Group 1: AH was given as a 0.00625%
solution in the drinking water for the life span
of 50 female and 50 male mice which were
6 weeks (44 days) old at the beginning of the
experiment. The average daily consumption
of water containing AH per animal was
7.7 ml for the females and 13-8 ml for the
males. Therefore, the average daily intake
of AH was 0-48 mg for a female and 0-86 mg
for a male.
Group 2: As untreated controls 100 female
and 100 male mice were kept and observed
from the time of weaning (5 weeks of age).
The experimental and control animals
wNere carefully checked and weighed at weekly
intervals and the gross pathological changes
were recorded. The animals were either
allowed to die or were killed with ether when
found in poor condition. Complete necropsies
were performed on all animals. All organs
ere examined macroscopically and were
fixed in 10% buffered formalin. Histological
studies ere made ofthe liver, spleen, kidney,
bladder, thyroid, heart, pancreas, testis,
brain, nasal turbinale and at least 4 lobes of
the lungs of each mouse as well as other
organs showing gross pathological changes.
Sections from these tissues were stained
routinely mith haematoxylin and eosin.
RESULTS
The treatment significantly shortened
the survival time when compared with
the life span of the untreated controls.
At the 80th, 90th and 100th weeks, 22, 10
and 3 females and 8, 5 and 1 males were
alive in the treated groups while in
controls the corresponding figures were
71, 57 and 36 females and 65, 48 and 27
males, respectively.
The number, percentage of animals
with tumours and the average age at
death are summarized in the Table. The
two most important lesions are described in
detail.
Lung tumours
Of the treated females, 38 (76%)
developed 86 such neoplasms. Of these,
21 mice had 33 adenomata, 5 had 9
adenocarcinomata and 12 had 26 adeno-
mata and 18 adenocarcinomata. The
average age at death was 80 weeks; the
first was found at the 60th week and the
last at the 100th week of age. In the
treated males, 16 (330o) developed 35 lung
tumours. Of these, 9 mice had 16
adenomata, 1 had an adenocarcinoma and
6 had 11 adenomata and 7 adenocarcino-
mata. The average age at death was 75
weeks; the first was observed at the 37th
week and the last at the 100th week ofage.
By standard evaluation methods (Food
Protection Committee, Food and Nutri-
tion Board, 1960), the findings seem to be
statistically significant. This is based on
the fact that 50 animals/group were used
and a clear cut difference must appear
between 2 equal groups to be significant
(P 0 05). Because thetumourincidence
in the least affected group was between
20 and 3000, it should be between 38 and
5000 in the most affected group. As a
matter offact, the figure was higher in the
females.
Macroscopically and histologically,
these tumours were similar to those
found in other treated groups and de-
scribed previously in this laboratory
(Toth, Magee and Shubik, 1964; Toth and
Shimizu, 1974).
Blood ves8el tumours
Of the treated females, 11 (22%)
developed blood vessel tumours. Of
these, 2 had angiosarcomata in the liver,
2 had angiosarcomata in the subcutis, 1
had an angiosarcoma in muscle and in
lymph node, 2 had angiomata in ovary, 2
had angiomata in lymph node, 1 had an
angioma in the spleen and lymph node,
and 1 had an angioma in liver, ovary and
lymph node. The average age at death
was 83 weeks; the first was found at the
62nd week and the last at the 100th week
of age. In the treated males, 7 (14%)
developed such lesions. Out of these, 2
had angiosarcomata in the liver, 1 had
an angiosarcoma in a lymph node, 1 had
493H. SHIMIZU, D. NAGEL AND B. TOTH
t o6 ~C>
lc; 0
Ce;
0
4-
Q 0
O
a)
0
C0 0 0 o -
00 t
o~ N . aq"-
0 r-
ho l
1-
*
* 0
e CO
m
o 0
I 00
CaO
000 Z00c
>
C)0 t~
o .S t
O 0
0 CO ID t-
00 00
- 00
h CO
ho
-4 0s
co
0o
CO -a
G-q
00
C3)
C)
ho
hO
- Is
C"
-'C)
C1)
b0
0 -4
0
0
u
0 -4
494
Co CO
-Q.
*CO
0
.e
EN
pq
rq
O
0
0 co
(1
0
S
O4Q bo
9 4
Q
O
-TUMORIGENESIS BY n-AMYLHYDRAZINE HCL
an angiosarcoma inliver and lymph node, 2
had angiomata in lymph node and 1 had
an angioma in liver. Their average age at
death was 79 weeks; the first was observed
at the 47th week and the last at the
100th week of age.
Statistically, the finding is significant
according to the previously mentioned
evaluation technique. Blood vessel
tumour incidence in the least affected
group was between 4 and 10%; it should
be between 16 and 26% in the most
affected group, which is what was ob-
served.
Grossly and histologically, these
tumours were similar to those described
previously in this laboratory (Toth and
Wilson, 1971; Toth, 1973).
Other trumours
In a few instances, other types of
tumours were also seen, which are shown
in the Table. They occurred in low
incidences so that their appearance cannot
be attributed to the treatment.
Tu.nours in tntreated controls
The detailed descriptions of sponta-
neously occurring tumours have been
published recently. Their incidences are,
however, also included in the Table for
comparison.
DISCUSSION
This study proves for the first time the
tumorigenicity of n-amylhydrazine hydro-
chloride in Swiss mice. The work with
substituted hydrazines is part of our
systematic effort to reveal the possible
correlation between the chemical struc-
tures of hydrazines and tumour induction
at specific organ sites. To date, 5 ofthem,
namely 1,2-dimethyl-, ],1-dimethyl-,
ethyl-, carbamyl-, and now n-amyl-
hydrazines, induced tumours of the lungs
and blood vessels (Toth and Wilson, 1971;
Toth, 1973; Toth, Shimizu and Nagel,
1974). In addition, 1,1-dimethyl-hydra-
zine induced tumours of the kidneys and
the liver. Four compounds- hydrazine,
monomethyl-, n-butyl-, and 1-carbamyl-2-
phenylhydrazines-produced only lung
tumours (Toth, 1972c; Toth and Shimizu,
1974; Toth et al., 1974). Benzoyl-
hydrazine induced tumours of the lungs
and lymphoreticular tissue (Toth, 1972b).
It is therefore apparent that the various
substituents in the hydrazine molecule
have some sort oforgan specific neoplastic
action.
The presently used n-amylhydrazine
hydrochloride was synthesized and studied
in the hope that by increasing the length
of the alkyl chain, the tumour spectra
might be modified. This hypothesis was
based on the fact that the mono- and
dialkyl-derivatives ofhydrazineessentially
induced only 2 types oftumours, i.e. those
of the lungs and blood vessels. Our
expectation, however, did not turn out to
be correct since the induced tumour types
by n-amylhydrazine HC1 were identical
with those produced by other hydrazines
with shorter alkyl chains.
Tumorigenesis studies with hydrazines
were especially encouraged because these
syntheticcompounds arefoundextensively
in the environment and used in industry,
agriculture and medicine. The most not-
able among the compounds used in
industry are the rocket fuel components
hydrazine and monomethyl and 1,1-dim-
ethyl-hydrazines (The Merck Index, 1968).
Another important hydrazine studied was
2-hydroxyethylhydrazine, used in agricul-
ture asaplantgrowth retardant, especially
for pineapples (Gowing and Leeper, 1955)
In medicine, phenylhydrazine is an effec-
tive drug in ases of polycythaemia vera
and 1-carbamyl-2-phenylhydrazine is
known for its antipyretic action, although
it is not used currently in the USA. In
addition, 1-hydrazinophthalazine is used
as an antihypertensive agent, while /-
phenylethylhydrazine is administered in
treatment of mentally depressed patients
(The Merck Index, 1968).
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